Search results
Showing 31 to 45 of 72 results for metastatic prostate cancer
used in routine clinical practice for treating hormone relapsed metastatic prostate cancer that has been previously treated with...
Irreversible electroporation for treating prostate cancer (IPG768)
Evidence-based recommendations on irreversible electroporation for treating prostate cancer. This involves using electrical pulses to destroy the cancer cells.
View recommendations for IPG768Show all sections
High-intensity focused ultrasound for prostate cancer (IPG118)
Evidence-based recommendations on high-intensity focused ultrasound for treating prostate cancer. This involves inserting a probe through the rectum that gives out a beam of ultrasound to heat and destroy the cancerous prostate tissue.
Spinal metastases and metastatic spinal cord compression (NG234)
This guideline covers recognition, referral, investigation and management of spinal metastases and metastatic spinal cord compression (MSCC). It is also relevant for direct malignant infiltration of the spine and associated cord compression. It aims to improve early diagnosis and treatment to prevent neurological injury and improve prognosis.
Awaiting development Reference number: GID-TA11202 Expected publication date: TBC
In development Reference number: GID-TA11583 Expected publication date: TBC
Awaiting development Reference number: GID-TA11558 Expected publication date: TBC
Awaiting development Reference number: GID-TA11827 Expected publication date: TBC
Awaiting development Reference number: GID-TA11438 Expected publication date: TBC
Awaiting development Reference number: GID-TA11534 Expected publication date: TBC
In development Reference number: GID-TA11766 Expected publication date: TBC
Awaiting development Reference number: GID-TA11049 Expected publication date: TBC
Discontinued Reference number: GID-TA10492
Discontinued Reference number: GID-TA10490
Discontinued Reference number: GID-TA10668